Chuck Cullen
General Partner and CFO @ Grotech Ventures
Hunt Valley, United States
Chuck Cullen is a General Partner and CFO at Grotech Ventures. He attended Northwestern University - Kellogg School of Management, Notre Dame Law School, and the University of Notre Dame.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Chuck Cullen invests in
Stages Chuck Cullen invests in
Countries Chuck Cullen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 2 (50%)
- SaaS 1 (25%)
- Fitness 1 (25%)
- Medical 1 (25%)
- Wellness 1 (25%)
Stage
- Series B 2 (50%)
- Series A 1 (25%)
- Funding Round 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
WiserTogether
|
WiserTogether’s personalized healthcare treatment comparison software enables consumers to choose the right treatment – most effective in the outcome, most personally suitable, and most cost-effective and affordable. The result is improved health and improved costs for consumers, their employers, payers, and providers. The company serves over 3million people through their employers and health plans. It was founded in 2008 and is based in Washington, District of Columbia. | $9M / Series B / Sep 24, 2014 | |
|
WiserTogether
|
WiserTogether’s personalized healthcare treatment comparison software enables consumers to choose the right treatment – most effective in the outcome, most personally suitable, and most cost-effective and affordable. The result is improved health and improved costs for consumers, their employers, payers, and providers. The company serves over 3million people through their employers and health plans. It was founded in 2008 and is based in Washington, District of Columbia. | $750K / Aug 01, 2013 | |
|
WiserTogether
|
WiserTogether’s personalized healthcare treatment comparison software enables consumers to choose the right treatment – most effective in the outcome, most personally suitable, and most cost-effective and affordable. The result is improved health and improved costs for consumers, their employers, payers, and providers. The company serves over 3million people through their employers and health plans. It was founded in 2008 and is based in Washington, District of Columbia. | $3M / Series A / Oct 17, 2011 | |
OpenQ
|
OpenQ enables social and mobile collaboration to create competitive advantage while overcoming regulatory compliancechallenges and legal risk exposure. OpenQ is a cloud-based technology and validated-data provider with the largestsuite of solutions for regulated industries. Our products help life sciences, health care, financial services andconsumerorganizations recognize the value of customer collaboration while remaining secure. The company offers award-winning, efficient and effective solutions for social compliance, compliant content management and key stakeholder engagement. Headquartered in New York City, OpenQ has a growing client list that spans the globe, including Global Fortune 500 companies, healthcare organizations andearly stage biotech companies. OpenQ invests heavily in product development, adapting to meet the changing needs of our customers with an evolutionary, continuous improvement approach. Our modular solutions work as Software-as-a-Service (SaaS) and Data-as-a-Service (DaaS) and are available on a variety of platforms. Solutions come industry-ready with policies for day-one implementation.To learn more about OpenQ’s offerings, visit http://www.OpenQ.com. Follow us on Twitter @OpenQinc, or on LinkedIn and Facebook | $5.5M / Series B / Jul 14, 2011 |
Co-Investors
About Grotech Ventures
As one of the established firms in the venture industry, Grotech Ventures has built a reputation for being a collaborative, long-term partner for CEOs and entrepreneurs by aligning their definition of success with that of their partners.They initially invest between $500,000 and $5 million in high-growth technology companies, reservingsignificant capital for subsequent investments to support companies through their early and growth stages.They look to partner with entrepreneurs who have fresh ideas, breakthrough innovations, and unconventional approaches that will yield explosive growth. They believe that their ability to meaningfully contribute to a business’s development is just as important as the capital they invest. As such, they seek investment opportunities that offer them the chance to leverage the experience, insight, and network they have built since their inception in 1984. Their approach is personal and long-term, not institutional.
Grotech Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Don Rainey
Venture Partner
|
|||
Steve Fredrick
General Partner
|
|||
|
Chuck Cullen
General Partner and CFO
|
|||
Darren Appanah
Vice President
|
|||
Frank Adams
Managing General Partner, Executive Chairman, and Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chuck Cullen invest in?
Chuck Cullen invests primarily in Software, SaaS and Fitness startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chuck Cullen?
Public channels for Chuck Cullen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Chuck Cullen last invest?
The most recent investment recorded for Chuck Cullen closed in Sep 2014. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
